Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With Acute Lymphoblastic Leukemia
Clinical trial NCT02186860 · UNKNOWN
Trial details
- NCT number
- NCT02186860
- Sponsor
- Affiliated Hospital to Academy of Military Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2021-10-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.